HHLR Advisors (Hillhouse)
SuperinvestorHHLR Advisors, Ltd.
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
- Latest filing
- Aug 14, 2026
AVBP holding history
ArriVent BioPharma, Inc. in every 13F filed by HHLR Advisors (Hillhouse), including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVBP overviewAll 13F holders of AVBPFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,929,117
- Value
- $136.5M
- % of portfolio
- 16.4%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,929,117 | $136.5M | 16.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,929,117 | $90.6M | 5.4% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,929,117 | $79.1M | 2.5% | −555,555−12.4% | Reduced | Holders |
| Q3 2025 | 4,484,672 | $82.7M | 2.0% | 00.0% | Unchanged | Holders |
| Q2 2025 | 4,484,672 | $97.6M | 3.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 4,484,672 | $82.9M | 2.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,484,672 | $119.5M | 4.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,484,672 | $105.4M | 2.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 4,484,672 | $83.2M | 2.1% | +555,555+14.1% | Added | Holders |
| Q1 2024 | 3,929,117 | $70.2M | 1.5% | +3,929,117 | New | Holders |